Usage and Awareness of Antiviral Medications for Coronavirus Disease 2019 (COVID-19) Among Individuals at Risk for Severe COVID-19, March 2021 to 1 August 2022
- PMID: 36069403
- DOI: 10.1093/cid/ciac743
Usage and Awareness of Antiviral Medications for Coronavirus Disease 2019 (COVID-19) Among Individuals at Risk for Severe COVID-19, March 2021 to 1 August 2022
Conflict of interest statement
Potential conflicts of interest. N. K. is a consultant for Curative. J. D. K. is an independent consultant and serves as the Medical Director of Curative. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019.Clin Infect Dis. 2023 Feb 18;76(4):563-572. doi: 10.1093/cid/ciac673. Clin Infect Dis. 2023. PMID: 35986628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
